Last reviewed · How we verify

[18F]MNI-1054

Invicro · Phase 1 active Small molecule

[18F]MNI-1054 is a Small molecule drug developed by Invicro. It is currently in Phase 1 development.

At a glance

Generic name[18F]MNI-1054
SponsorInvicro
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about [18F]MNI-1054

What is [18F]MNI-1054?

[18F]MNI-1054 is a Small molecule drug developed by Invicro.

Who makes [18F]MNI-1054?

[18F]MNI-1054 is developed by Invicro (see full Invicro pipeline at /company/invicro).

What development phase is [18F]MNI-1054 in?

[18F]MNI-1054 is in Phase 1.

Related